History

1954–1964
- Krka Pharmaceutical Laboratory was established
- Krka Production Plant was established
- the first patent was registered
- Krka re-locates to Ločna where a major part of production still occurs today
- Establishment of the Development Institute
- First cosmetic products launched
- First export ventures
1965–1974
- Construction of the new plant for manufacturing active ingredients
- Extension of a new plant for manufacturing tablets and coated tablets
- Construction of a new plant for producing ointments, syrups and injections
- Collection and processing of medicinal herbs
- Expansion to tourist and spa services
- Presentation of the first Krka Awards
1975–1984
- registration granted by the American FDA for the manufacture of antibiotics
- the Dawa Pharmaceutical production plants began operation in Kenya
- fermentation capacities were increased by 50 %
- construction of a plant for converting pharmaceutical active ingredients into finished products
- investment in preservation of clean waters and environment protection
- construction of the factory in Ljutomer
- investment in tourist/health-resort facilities
1985–1994
- construction of a plant producing insulation material
- building marketing network abroad (establishment of companies and representative offices)
- accelerated development of Krka’s own generic drugs, and continual cooperation with the leading international pharmaceutical companies
- ranking in the top Slovene companies and exporters
- modernisation of fermentation production
- ensuring a highly qualified professional work force through the project of staff development
- increased investment in research and development
1995–2000
- top-place ranking among pharmaceutical companies in Central and Eastern Europe, and penetration into Western European markets
- investment in research and development activities
- upgrading the Total Quality Management system
- restructuring into a joint-stock company
2001–2005
- completion of the construction of the modern plant Notol for the production of solid dosage at the central Krka location
- expansion of production-distribution network abroad (new production-distribution plants in Poland, the Russian Federation and in Croatia)
- a new plant for the production of solid dosage forms in Šentjernej
- expansion of marketing and sales network
- Development and Control Centre 2
- Acquisition of ISO 14001 standard (new quality in environment protection)
- Implementation of the new SAP information system
- Acquisition of the foodstuff safety system certificate (HACCP), safety and health at work (OHSAS 18001) and the certificate by the European Agency for Safety and Health at Work (EU-OSHA)
- Construction of the plant for the production of active pharmaceutical ingredients Synthesis 4
2006–2010
- Expansion of the marketing and sales network
- Opening of Sinteza 4 API plant
- Introduction of no-par value shares (1:10 share split)
- Acquisition of ISO/IEC 27001 certificate for the information security system
- Highest national award for quality – the Business Excellence Award of the Republic of Slovenia (PRSPO) for 2007.
- Opening of the new injection production plant
- A new business centre for warehousing products, customs operations and marketing activities in Macedonia
- Entry into a private Chinese pharmaceutical and chemical companies Zhejiang Menova Pharmaceuticals Co., Ltd., Shanghai and Anhua Menova Pharmaceuticals Co., Ltd., Gvande
- Purchase of German company TAD Pharma GmbH from Cuxhavna and Austrian company Alternova Arzneimittell GmbH from Vienna
- New chemical development laboratories
2011–2020
- Opening of a state-of-the-art syrup production plant
- Opening of a state-of-the-art plant for the production of products with biocidal effect
- Starting the solar power plant
- Renovation and enlargement of a high bay warehouse for packaging material
- Opening of a state-of-the-art solid dosage forms production plant
- Opening of development and control centre RKC 3
- Listing of Krka's shares on the Warsaw Stock Exchange
- Founding the company Farma GRS, d. o. o., together with partners within the pharmaceutical industry development project and building development and research, and production capacities
- Opening of the Krka-Rus 2 plant in the Russian Federation
- Opening of the plant for the production of active pharmaceutical ingredients Sinteza 1 in Krško
- Opening of the largest investment in Krka's history – a plant for the production of solid dosage forms Notol 2 with an annual production capacity of 4.5 billion of finished products
- Opening of a plant for the new generation lozenges in Ljutomer
- Opening of development and control centre RKC 4
- Strengthening the marketing and sales network comprising 28 subsidiaries and 19 representative offices together with production and distribution companies